✦ LIBER ✦

Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal

✍ Scribed by Patricia M. Lopez; Augusto Villanueva; Sasan Roayaie; Josep M. Llovet

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 133 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21018

No coin nor oath required. For personal study only.

✦ Synopsis

Hepatocellular carcinoma (HCC) is a major health problem, being the fifth most common cancer worldwide. 1 The incidence of HCC is increasing in Europe and the United States, 2 and it is currently the leading cause of death among patients with cirrhosis. 3 The advent of surveillance programs has led to a change in the stage of tumors detected. In more than half of the cases, these tumors will be suitable for potentially curative treatments, such as resection, transplantation, and percutaneous ablation. 4,5

📜 SIMILAR VOLUMES

Sorafenib therapy in patients with hepat

Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation

✍ Ian A. Rowe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

The team of Liu et al. generated endoderm-derived human induced pluripotent stem (iPS) cells from primary hepatocytes. 1 However, they generated human iPS cells by using viral transgenes. 1 Clinical applications of human iPS cells require avoiding viral transgenes. On the other hand, the reprogrammi

Role of locoregional therapy for hepatoc

Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: Answer or myth?

✍ Teh-Ia Huo; Shou-Dong Lee; Jaw-Ching Wu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

Reply: Role of locoregional therapy for

Reply: Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: Answer or myth?

✍ Paige Porrett; Abraham Shaked; Kim Olthoff 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Huo and colleagues 1 appropriately note that the low complete response rate to radiofrequency ablation (RFA) in our study contrasts markedly with much of the published literature. Their surprise regarding this finding originates from the commonly held belief that RFA effectively ablates hepatocellul

Treatment of hepatocellular carcinoma in

Treatment of hepatocellular carcinoma in cirrhosis: Locoregional therapies for bridging to liver transplant

✍ Fred T. Lee Jr. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Hepatocellular carcinoma (HCC) in the setting of cirrhosis continues to increase in both the United States and abroad because of the widespread incidence of hepatitis B and C. Before the advent of transplantation, liver resection was the only method to achieve cure. However, resection is associated

What is the role of adjuvant therapy aft

What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?

✍ Christophe Duvoux; Tetsuya Kiuchi; Bernhard Pestalozzi; Ronald Busuttil; Rebecca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 1 views

Diagnostic imaging of hepatocellular car

Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation

✍ Bachir Taouli; Glenn A. Krinsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

1. The lack of whole-liver explant correlation has led to an overestimation of the sensitivity of imaging tests for the diagnosis of HCC in the radiological literature. 2. Ultrasound is insensitive for the diagnosis of HCC in the cirrhotic liver and should not be used for the detection of focal live